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Abstract
Certain activating immune receptors expressed on myeloid cells non-covalently associate with
either DAP12 or FcRγ chain, the immunoreceptor tyrosine-based activating motif (ITAM)-
bearing transmembrane adapter proteins.  An activating receptor, myeloid-associated
immunoglobulin-like receptor (MAIR)-II, is expressed on a subset of B cells and
macrophages in the spleen and peritoneal cavity of mice and associates with DAP12 in these
cells.  However, we demonstrate here that cross-linking MAIR-II with monoclonal antibody
induced secretion of significant amount of the inflammatory cytokines TNF-α and IL-6 from
DAP12-/- as well as wild type peritoneal macrophages.  We show that MAIR-II associates
with not only DAP12 but also FcRγ chain homodimers in peritoneal macrophages.  LPS
enhanced the FcRγ chain expression and FcRγ chain-dependent cell surface expression of
MAIR-II and had additive effects on MAIR-II-mediated inflammatory cytokine secretion
from peritoneal macrophages.  The lysine residue in the transmembrane region of MAIR-II
was involved in the association with FcRγ chain as well as DAP12.  Our findings present the
first case of an activating receptor that uses either DAP12 or FcRγ chain as a signaling adapter.
FcRγ chain may provide cooperation with and/or compensation for DAP12 in MAIR-II-
mediated inflammatory responses by peritoneal macrophages.
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Introduction
Antigen recognition by the T cell antigen receptor (TCR) and the B cell antigen receptor
(BCR) initiates signals for activation, cell differentiations, and effector function via the non-
covalently associating transmembrane (TM) adaptor molecules CD3γ, CD3δ, CD3ε, and ζ
subunits of the TCR and α and β subunits of BCR, respectively.  These adapter proteins bear
immunoreceptor tyrosine-based activation motifs (ITAM) in their cytoplasmic regions, which
are tyrosine phosphorylated by src family protein tyrosine kinases (PTKs) after antigen
recognition, resulting in activation of down stream signaling molecules.
Fc receptors, including the high affinity IgE receptor (FcεRI), the IgG receptors
(FcγRI, III, and IV) and the receptor for IgA (FcαRI; CD89), also associate with the ITAM-
bearing adapter FcRγ chain that is responsible for Fc receptor-mediated cell activation (1).
FcRγ chain is also an adapter that associates with several myeloid cell-specific receptors,
including mouse PIR-A (2, 3) and human ILT-1 (4) and ILT-7 (5).
DAP12 (6), also named killer-cell activating receptor-associated protein (KARAP)
(7), is another family member of ITAM-containing TM adapter proteins.  DAP 12 is
expressed in NK cells and associates with several activating NK receptors (reviewed in (8)),
and is also expressed in myeloid cells.  Several myeloid cell-specific receptors that associate
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with DAP12 have been reported, including human and mouse TREM-1, TREM-2, MDL-1,
and PILRβ, human SIRPβ, and mouse TREM-3 and CD200RLa (reviewed in (9)).
We have recently identified paired activating and inhibitory immunoglobulin-like
receptors, designated myeloid-associated immunoglobulin-like receptor (MAIR)-I and MAIR-
II, whose extracellular domains are highly conserved with each other (10).  MAIR-I, also
named LMIR-1 (11) or CMRF-35-like molecule (CLM)-8 (12), contains immunoreceptor
tyrosine-based inhibitory motifs (ITIM) in its cytoplasmic domain, and inhibits IgE-mediated
degranulation of mast cells (10, 13).  On the other hand, MAIR-II, also named LMIR-II (11),
CLM-4 (12) or DIgR1 (14), is expressed on subsets of peritoneal macrophages and B cells
and associates with DAP12, which  mediates activating signals, resulting in inflammatory
cytokine secretion from macrophages (10).  By screening a macrophage cDNA library and the
mouse genome, we and another group found that MAIR-I and MAIR-II are members of a
multigene family consisting of at least 9 genes on a small segment of mouse chromosome 11
(our unpublished observation and (12)).  MAIR family genes are most similar to the human
CD300 family (CMRF), which is located on human chromosome 17 (15), syntenic region of
mouse chromosome 11.
The family of TM adapter proteins described above are all characterized by a small
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extracellular region, an aspartic acid (D), a negatively charged amino acid, in the TM domain,
and a cytoplasmic domain that contains one or more ITAM (16).  Receptors that associate
with these TM adapters have a positively charged amino acid, such as lysine (K) or arginine
(R), in their TM region and possess short cytoplasmic regions without any signaling motif.
Certain activating immune receptors expressed on lymphoid and myeloid cells selectively
associate either with DAP12 or FcRγ; however, there is not prior evidence that a receptor can
pair with both of these adapter proteins. We demonstrate here that MAIR-II physically and
functionally associates with not only DAP12 but also FcRγ chain in peritoneal macrophages.
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Materials and Methods
Mice
C57BL/6J mice were purchased from Clea (Tokyo, Japan).  DAP12-deficient and FcRγ
chain-deficient mice were previously described (17, 18).  These mutant mice were
backcrossed to C57BL/6J mice for nine generations.  All experiments were performed
according to the guidelines of the animal ethics committee of the University of Tsukuba
animal research center.
Cells and transfectant
Mouse peritoneal macrophages were collected by peritoneal lavage with 5 ml of PBS
from 8 to 12 week old mice before or three days after i.p. injection of 2 ml of 4% sterile
thioglycollate.  B cells and macrophages from the spleen and peritoneal cavity were
purified by using a MACS selection system with biotin-conjugated anti-B220 mAb and
streptavidin-coated MicroBeads (Miltenyi Biotec, Bergisch Granbach, Germany) and
anti-CD11b MicroBeads, respectively.  Bone marrow cells were cultured in the presence
of M-CSF (10 ng/ml) for 4 days and analyzed by flow cytometry, showing that more
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than 80 % of cultured cells were CD11b+  macrophages.   RBL-2H3 transfectant stably
expressing MAIR-II-IRES GFP and N-terminus Flag-tagged DAP12 and the BW5147
transfectant stably expressing N-terminus Flag-tagged FcRγ chain, as described
previously (10).  The 2B4 transfectant stably expressing N-terminus Flag-tagged
DAP12 was provided by Hisashi Arase (Osaka University, Japan).  These BW5147 and
2B4 transfectants were further transfected with WT or mutated MAIR-II, which
contained a codon for A195 (GCG) instead of K195 (AAG), as described (10).
Antibodies
Control rat IgGs, anti-CD11b and anti-CD16/CD32 2.4G2 mAbs were purchased from
BD Biosciences (San Jose, CA); anti-phosphotyrosine (4G10) and anti FcεRIγ (FcRγ
chain) mAbs were purchased from Upstate Biotechnology (Lake Placid, NY); anti-
p42/44 ERK and anti-phospho p42/44 ERK were purchased from Cell Signaling
(Beverly, MA); and rabbit anti-Flag polyclonal antibody was purchased from Sigma-
Aldrich.  Anti-mouse DAP12 polyclonal antibody was a gift from M. Ono (Tohoku
University School of Medicine, Sendai, Japan).  TX52 (anti-MAIR-II) mAb was
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generated in our laboratory as described previously (10).  F(ab’)2 fragments of TX52
mAb were prepared, as described previously (10).  Purity of the F(ab’) 2 fragments were
determined by SDS-PAGE.  To exclude LPS contamination, antibodies were treated
with polymixin B (10 ug/ml; Sigma Aldrich) before use.
Biochemistry
Cells were lysed in 1% digitonin (Calbiochem, San Diego, CA), 0.12% Triton-X
(Sigma-Aldrich), 150 mM NaCl, 20 mM triethanolamine, and protease and phosphatase
inhibitors.  After overnight pre-clearing with 2.4G2mAb-conjugated agarose beads
(ImmunoPure Immobilized Protein L, Pierce Chemical), immunoprecipitations and/or
immunoblotting experiments were performed, as described (10).  For tyrosine
phosphorylation studies, cells were stimulated with F(ab’)2 fragments of control rat IgG
or anti-MAIR-II (TX52), followed by crosslinking with F(ab’)2 fragments of rabbit anti-
rat IgG (Southern Biotechnology, Birmingham, AC).  For stripping and re-blotting,
Restore Western Blot Stripping Buffer (Pierce Chemical) was used according to the
manufacturer’s instruction.
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Stimulation of macrophages and cytokine measurement
Peritoneal macrophages (5x105/well) were stimulated for 24 hrs in 96-well flat-bottom
plates coated with F(ab’)2 fragments of control rat IgG or anti-MAIR-II (TX52).  The
amounts of TNF-α and IL-6 were measured by enzyme-linked immunosorbent assay
(ELISA; BD Pharmingen, Franklin Lakes, NJ).
Statistics
Statistical analyses were performed by unpaired Student’s t-test.
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RESULTS
MAIR-II mediates pro-inflammatory cytokine production from DAP12-deficient
peritoneal macrophages
We previously demonstrated that MAIR-II was co-immunoprecipitated with DAP12,
but not FcRγ chain, in primary spleen cells (10).  Because MAIR-II was expressed on
subsets of B cells and macrophages in spleen, we first examined whether MAIR-II
associated with DAP12 either in B cells, macrophages or both.  We demonstrate that
MAIR-II was co-immunoprecipitated with DAP12 in both B220+ B cells and CD11b+
macrophages purified from spleen (Fig. 1).  Further experiments showed similar results
in B220+ B cells and CD11b+ macrophages purified from peritoneal exudative cells
(PEC) (Fig. 1), suggesting that DAP12 is a physiological partner of MAIR-II in B cells
and macrophages in the spleen and peritoneal cavity.  In fact, whereas splenic
macrophages from WT mice produced TNF-α when stimulated with F(ab’)2 fragments
of anti-MAIR-II mAb, DAP12-/- macrophages did not respond to the antibody
stimulation for TNF-α secretion (Fig. 2), indicating that DAP12 is required for MAIR-
II-mediated activating signal in splenic macrophages.  Unexpectedly, however, cross-
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linking MAIR-II produced significant amount of both TNF-α and IL-6 from DAP12-/-
as well as WT peritoneal macrophages (Fig. 2).  These results suggest that another
MAIR-II-associating adapter molecule, in addition to DAP12, may mediate activating
signals specifically in peritoneal macrophages.
MAIR-II associates with FcRγ chain as well as DAP12 in peritoneal macrophages
Because B cells and macrophages express FcRγ chain as well as DAP12 (10), we
investigated whether MAIR-II also associates with FcRγ chain in these cells from the
spleen and PEC.  We observed co-immunoprecipitation of MAIR-II with FcRγ chain in
lysates of peritoneal macrophages and bone marrow-derived cultured macrophages (Fig.
1).  Moreover, it was significantly enhanced after culture of peritoneal macrophages in
the presence of LPS (Fig. 1), suggesting that not only DAP12 but also FcRγ chain
associates with MAIR-II in peritoneal macrophages.  In contrast, association of MAIR-
II with FcRγ chain was not detected in splenic B cells and macrophages and peritoneal
B cells, even after culture in the presence of LPS (Fig. 1).
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MAIR-II mediates activating signals through both DAP12 and FcRγ chain in
peritoneal macrophages
 The signaling pathways downstream of DAP12 and FcRγ chain have well been
characterized; both adapter proteins activate a common pathway, including stimulation
of Src family PTKs, which phosphorylate ITAMs on tandem tyrosine residues, thereby
leading to the recruitment and activation of PTKs of Syk family and subsequent
downstream signal transduction (9, 19).   ERK is a tyrosine phosphorylated signaling
molecule downstream of both DAP12 and FcRγ chain.  To determine whether either
DAP12, FcRγ chain, or both mediate signals after cross-linking MAIR-II, we stimulated
peritoneal macrophages derived from WT, DAP12-/-, FcRγ-/-, and double-deficient
mice (DKO) with F(ab’)2 fragments of anti-MAIR-II mAb.  Immunoblotting studies
demonstrated that ERK 1/2 were tyrosine phosphorylated after stimulation with anti-
MAIR-II in peritoneal macrophages from WT, DAP12-/- and FcRγ-/-, but not DKO,
mice (Fig. 3A).  Consistent with these signaling events, cross-linking MAIR-II also
induced TNF-α and IL-6 productions from WT, DAP12-/-, and FcRγ-/- peritoneal
macrophages, but not from DKO mice (Fig. 3B).  Taken together, these results suggest
Nakahashi et al
13
that both DAP12 and FcRγ chain are responsible for MAIR-II-mediated activating
signals in peritoneal macrophages.
LPS enhances FcRγ chain-dependent cell surface expression of MAIR-II in
peritoneal macrophages
We demonstrated that LPS enhanced the association of MAIR-II with FcRγ chain, but
not DAP12 (Fig. 1), suggesting that LPS up-regulates FcRγ chain expression,
accelerating the complex formation and cell surface expression of MAIR-II and FcRγ
chain.  In fact, we found that overnight culture with LPS induced up-regulation of FcRγ
chain expression in WT peritoneal macrophages (Fig. 4A).  In contrast, DAP12
expression was not affected by LPS in peritoneal macrophages (Fig. 4A), although it
was enhanced after culture in the presence of LPS in spleen B cells (10).  Moreover,
whereas peritoneal macrophages derived from WT, DAP12-/-, FcRγ -/-, and DKO mice
expressed comparable amount of MAIR-II on the cell surface, culture in the presence of
LPS upregulated cell surface expression of MAIR-II in WT and DAP12-/-, but not
FcRγ-/- and DKO, peritoneal macrophages (Fig. 4B).  Together, these results suggested
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that LPS enhanced FcRγ chain-dependent cell surface expression of MAIR-II.   In
contrast with LPS, both a Th1 cytokine interferon (IFN)-γ and a Th2 cytokine IL-4,
which are thought to induce classical and alternative activation of macrophages,
respectively (20), did not have any effects on cell surface expression of MAIR-II on
peritoneal macrophages (data not shown).   
We next examined whether LPS had any effect on MAIR-II-mediated signaling
in peritoneal macrophages as a result of enhancement of cell surface expression of
MAIR-II.  To address this question, peritoneal macrophages were cultured in the
presence of LPS and then stimulated with F(ab’)2 fragments of anti-MAIR-II mAb.
Stimulation with LPS alone significantly induced TNF-α secretion from WT, DAP12-/-,
FcRγ-/-, and DKO peritoneal macrophages.  Cross-linking MAIR-II further increased
TNF-α secretion from WT and DAP12-/-, but not from FcRγ-/- or DKO, peritoneal
macrophages that had been stimulated with LPS (Fig. 4C), indicating that LPS-induced,
FcRγ chain-dependent MAIR-II expression could amplify inflammatory responses by
peritoneal macrophages.
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MAIR-II associates with DAP12 or FcRγ chain homodimers
To determine whether DAP12 and FcRγ can form heterodimers, we transfected a rat
basophilic leukemia, RBL-2H3, which does not express MAIR-II and DAP12, but does
FcRγ chain (21), with a MAIR-II-IRES-GFP construct together with Flag-tagged
DAP12.  Experiments were performed to examine whether both DAP12 and FcRγ chain
were co-immunoprecipitated with MAIR-II by using anti-Flag or anti-FcRγ chain mAbs.
As demonstrated in Fig. 5, MAIR-II was co-immunoprecipitated with either
homodimers of DAP12 or FcRγ chain.  Heterodimers between DAP12 and FcRγ were
not observed.
The lysine residue in the TM region of MAIR-II is involved in association with
both DAP12 and FcRγ chain
Because MAIR-II contains a lysine TM region, but not an arginine, in the TM region, a
question was raised whether the lysine residue is involved in the association with FcRγ
chain as well as DAP12.  We generated WT and mutant MAIR-II cDNA, which encoded
MAIR-II containing an alanine instead of the lysine in the TM region.  These cDNA
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were introduced into the 2B4 and BW5147 mouse T cell transfectants stably expressing
Flag-tagged DAP12 and Flag-tagged FcRγ chain, respectively.  As demonstrated in Fig
6A, whereas introducing WT MAIR-II into Flag-tagged DAP12-expressing 2B4 induced
cell surface expression of DAP12, introduction of the mutant MAIR-II did not.
Similarly, in contrast with WT MAIR-II, mutant MAIR-II also did not induce cell surface
expression of FcRγ chain.  Moreover, FcRγ chain as well as DAP12 were co-
immunoprecipitated with WT, but not mutant, MAIR-II (Fig. 6C).  Together, these
results indicated that the lysine residue in the TM region of MAIR-II was involved in
the association with FcRγ chain as well as DAP12.  
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Discussion
We have presented here the first case of an activating receptor that uses either DAP12 or
FcRγ chain as the signaling adapter.  At present, it is unclear whether any other
activating receptors on myeloid or lymphoid cells have a similar property.  Although
NKG2D non-covalently associates with DAP10 in CD8+ T cells, a mouse NKG2D
isoform pairs with either DAP10 or DAP12 in activated mouse NK cells (22, 23).
Unlike DAP12, DAP10 has a YxxM motif in the cytoplasmic domain, which recruits
the p85 subunit of the phosphatidylinositol 3-kinase (PI 3-kinase), thereby providing a
different function from DAP12.  On the contrary, DAP12 and FcRγ chain seem to
initiate the same signal transduction pathways by recruiting Syk and/or ZAP70 (19).
Because LPS enhanced FcRγ chain expression and FcRγ chain-dependent cell surface
expression of MAIR-II on peritoneal macrophages, FcRγ chain may provide
cooperation with and/or compensation for DAP12 in MAIR-II-mediated inflammatory
responses mediated by peritoneal macrophages.
Several activating receptors, including CD16, NKp46, and NKp30, associate
with heterodimers of FcRγ and ζ, as well as the homodimer of these adapter proteins
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(24), suggesting that FcRγ and ζ are redundant.  We have demonstrated that MAIR-II
associated with either the homodimers of DAP12 or FcRγ, but not the heterodimers of
DAP12 and FcRγ.  These results were reasonable, because, unlike FcRγ and ζ, DAP12
and FcRγ chain have the extracellular cysteines and the TM aspartic acid residues at
quite different positions from each other, which may prevent the heterodimer formation
by these two adapter proteins.  Specifically, DAP12 has two cysteine residues per chain
in the membrane-proximal extracellular region, which may be involved in dimer
formation, whereas FcRγ chain has one cysteine per chain in the TM domain (16).
Moreover, the negatively charged residue aspartic acid, which is involved in physical
association with activating receptors containing a positively charged amino acid residue
in the TM domain, is located close to the center of the TM region of DAP12, but it is in
the N-terminal segment of the TM domain of FcRγ chain (16).
DAP12, which has an aspartic acid close to the center of the TM region,
preferentially associates with immune receptors, including NK receptors and activating
myeloid receptors, which bear a charged amino acid residue (usually lysine) at the
center, rather than at the N-terminal segment, of the TM domain (16).  In contrast, FcRγ
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chain has an aspartic acid in the the N-terminal segment of the TM region and non-
covalently associates with immune receptors, including several Fc receptors and others,
which bear a charged amino acid residue (often arginine) also at the N-terminal segment
of the TM domain.  Although the lysine residue in the TM region of MAIR-II is
involved in the association of MAIR-II with both DAP12 and FcRγ chain, it cannot be
concluded that the molecular and structural characteristics of the assemblies of MAIR-II
with FcRγ chain are similar to that with DAP12, because not only a charged amino acid
but also the orientation of receptors toward TM adaptors play an important role in
association of receptors with adaptors (25).  
We have demonstrated that, although MAIR-II associated with either DAP12
or FcRγ chain on peritoneal and bone marrow-derived cultured macrophages, it did with
DAP12 alone on macrophages from the spleen.  Macrophages are widely distributed in
tissues and have marked phenotypic heterogeneity, which are likely to result from
developmental signals encountered within individual tissue sites.  In addition, each
macrophage also acquires new functional capacities in response to stimuli encountered
in the tissue microenvironment.  These heterogeneity of tissue macrophages might lead
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to the functional difference also in the adapter usage of MAIR-II.  In contrast, B cells
from peritoneal cavity as well as the spleen expressed MAIR-II that associated with
DAP12 alone, probably because B cells may have little phenotypic heterogeneity
between tissues.  Future studies are required to clarify the molecular basis for the
assembly of both adapters by MAIR-II.
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Figure Legends
Figure 1.  MAIR-II associates not only with DAP12 but also with FcRγ chain in
peritoneal and bone marrow-derived cultured macrophages.
  B cells and macrophages purified from spleen and peritoneal exudative cells (PEC) or
bone marrow-derived cultured macrophages were cultured overnight in the presence or
absence of LPS (100 ng/ml).  Cells were lysed in 1% digitonin buffer,
immunoprecipitated with control Ig or anti-MAIR-II, and immunoblotted with anti-
DAP12, anti-FcRγ chain, or anti-MAIR-II.  Data are representative of three independent
experiments.
Figure 2. MAIR-II mediates cytokine production from DAP12-/-  as well as WT
peritoneal macrophages.
 Macrophages from the spleen and PEC derived from WT and DAP12-/- mice were
stimulated with plate-coated F(ab)’2 fragments of anti-MAIR-II or isotype-matched
control Ig for 68 h and 24 h, respectively.  Culture supernatants were harvested, and
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TNF-α and IL-6 concentrations were measured by ELISA.  Data are representative of
three independent experiments.
Figure 3.  Both DAP12 and FcRγ chain are involved in MAIR-II-mediated
signaling in peritoneal macrophages
Peritoneal macrophages from mice indicated were stimulated or not with plate-coated
F(ab)’2 fragments of anti-MAIR-II or isotype-matched control Ig for 5 min (A) or for 24
h (B).  The lysates were immunoblotted with anti-phospho-p42/44 ERK or anti-p42/44
ERK (A).  Culture supernatants were harvested, and TNF-α and IL-6 concentrations
were measured by ELISA (B).  Data are representative of five independent experiments.
Figure 4. LPS has additive effects on MAIR-II-mediated inflammatory cytokine
secretion from peritoneal macrophages
(A) 3 x 106 peritoneal macrophages from WT mice were stimulated or not with LPS
(100 ng/ml) for 48 hrs, lysed, and immunoblotted with anti-DAP12 or anti-FcRγ chain
(left).  Relative density of each signal was measured by densitometry (right).  (B) PEC
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from mice indicated were cultured in the presence or absence of LPS (100 ng/ml) for 48
hrs and then stained with Alexa 647-conjugated F(ab)’2 fragments of anti-MAIR-II
(open histogram) or isotype-matched control Ig (shaded histogram), together with anti-
CD11b and anti-F4/80. CD11b+ and F4/80+ cells were analyzed by flow cytometry.  (C)
Peritoneal macrophages from mice indicated were cultured overnight in the presence of
LPS (100 ng/ml) and then stimulated with plate-coated F(ab)’2 fragments of anti-MAIR-
II or isotype-matched control Ig for 24 hrs.  Culture supernatants were harvested and
TNF-α and IL-6 concentrations were measured by ELISA.  Data are representative of
four to five experiments.
Figure 5. MAIR-II associates with the FcRγ chain or DAP12 homodimers
 RBL-2H3 that constitutively expresses FcRγ chain was transfected with a MAIR-II-
IRES-GFP construct together with Flag-tagged DAP12 in a retrovirus vector.  Two days
after infection, MAIR-II expressing cells were sorted, based on GFP expression, lysed
and immunoprecipitated with control Ig, anti-Flag, or anti-FcRγ chain, and
immunoblotted with anti-MAIR-II, anti-Flag, or anti-FcRγ chain.
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Figure 6. The lysine residue of MAIR-II is involved in association of FcRγ chain as
well as DAP12 homodimers
    2B4 and BW5147 transfectants stably expressing Flag-tagged DAP12 and Flag-
tagged FcRγ chain, respectively, were transfected with WT or mutated (K195A)
MAIR-II in a retrovirus vector.  Two days after infection, cells were stained with
Alexa 647-conjugated anti-MAIR-II and biotin-conjugated anti-Flag mAbs,
followed by FITC-conjugated streptavidin, and analyzed by flow cytometry (A).
These cells were also lysed, immunoprecipitated with anti-MAIR-II, and
immunoblotted with anti-Flag or anti-MAIR-II (B).
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